Guided Therapeutics, Konica Minolta Holdings Inc. deal

Guided Therapeutics began a U.S. feasibility study under an amended 2010 deal with Konica Minolta's Konica Minolta Opto Inc. optics unit to use Guided Therapeutics' LightTouch technology to co-develop a product to detect and monitor Barrett's esophagus, a type of esophageal pre-cancer. The study is evaluating Guided Therapeutics' light-based technology in about 40 patients and is expected to be completed by year end. In March, the parties extended the 2010 deal to 2012 (see BioCentury, April 4). ...